Directory
>
Hasane Ratni
Hasane Ratni
Vice-President, Chemistry, Skyhawk Therapeutics | Skyhawk Therapeutics
Basel, Basel-City, Switzerland
Hasane Ratni
Summary
Hasane Ratni is a seasoned drug hunter with a remarkable track record of designing six molecules that have successfully advanced to human clinical trials. As the Vice-President of Chemistry at Skyhawk Therapeutics, he played a pivotal role in the invention of Risdiplam, the first approved small molecule targeting RNA. With over 80 patent applications and 35 peer-reviewed publications in prestigious journals like Science and Nature, Hasane is a prolific contributor to the field. His accolades include the Senior Industrial Award from the Swiss Chemical Society and the Drug Discovery of the Year Award for two consecutive years. Hasane's extensive experience in pharmaceutical research is complemented by his leadership roles at F. Hoffmann La Roche, where he has led various projects in neuroscience and rare diseases. His educational background includes a Ph.D. in Organic Chemistry from the University of Geneva and post-doctoral studies at the University of Tokyo. Hasane is not only a scientist but also a thought leader in drug discovery, with a passion for innovation and collaboration in the pharmaceutical industry.
Hasane Ratni
Work Experience
Vice-President, Chemistry, Skyhawk Therapeutics at
Skyhawk Therapeutics
May 2022 - Present
Distinguished Scientist and Project team leader at
F Hoffmann La Roche
October 2020 - May 2022
Expert Scientist, Project Leader Discovery Chemistry (Neuroscience and rare disease) at
F Hoffmann La Roche
May 2002 - October 2020
Expert Scientist and project team leader at
F Hoffmann La Roche
November 2018 - October 2020
Section head, Medicinal Chemistry (Neuroscience, Ophtalmology and Rare Disease) at
F Hoffmann La Roche
January 2018 - November 2018
Medicinal Chemist at
Chugai Pharmaceuticals
January 2005 - June 2005
Hasane Ratni
Education
université de Tokyo, Post-Doctoral Studies
January 2001 - January 2002
University of Geneva, Doctor Of Philosophy (Ph.D.)
January 1997 - January 2001
École Polytechnique, D.E.A (Master Degree) Multinational De Chimie Moleculaire
January 1998
Frequently Asked Questions about Hasane Ratni
What is Hasane Ratni email address?
Hasane Ratni's primary email address is ******@skyhawktx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Hasane Ratni work for?
Hasane Ratni is a Vice-President, Chemistry, Skyhawk Therapeutics at Skyhawk Therapeutics, a company specializing in Commercial physical research.
Where Hasane Ratni graduated from?
Hasane Ratni holds a degree in from université de Tokyo.
How can I directly contact Hasane Ratni?
To contact Hasane Ratni directly, you can use the email address ******@skyhawktx.com. Complete contact information is available upon registration with Muraena.
Is Hasane Ratni an immigrant?
Yes, Hasane Ratni is an immigrant and currently based in Switzerland
Who is Hasane Ratni?
Hasane Ratni is a seasoned drug hunter with a remarkable track record of designing six molecules that have successfully advanced to human clinical trials. As the Vice-President of Chemistry at Skyhawk Therapeutics, he played a pivotal role in the invention of Risdiplam, the first approved small molecule targeting RNA. With over 80 patent applications and 35 peer-reviewed publications in prestigious journals like Science and Nature, Hasane is a prolific contributor to the field. His accolades include the Senior Industrial Award from the Swiss Chemical Society and the Drug Discovery of the Year Award for two consecutive years. Hasane's extensive experience in pharmaceutical research is complemented by his leadership roles at F. Hoffmann La Roche, where he has led various projects in neuroscience and rare diseases. His educational background includes a Ph.D. in Organic Chemistry from the University of Geneva and post-doctoral studies at the University of Tokyo. Hasane is not only a scientist but also a thought leader in drug discovery, with a passion for innovation and collaboration in the pharmaceutical industry.
Hasane`s contact details
******@skyhawktx.com
Colleagues
Chief Scientific Officer
Vice President Corporate Development
Executive Director, Translational Biomarkers
Executive Director, Bioinformatics
Chief Medical Officer
Senior Vice President Chemistry
Senior Vice President Legal
Executive Director Discovery Biology